首页 › 转移性癌症 › 北卡罗来纳州 › Charlotte
Charlotte NC 转移性癌症临床试验
11项针对 转移性癌症的研究正在 Charlotte及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
招募中1/2 期
- Levine Children's Hospital- Pediatric Neuro-Oncology, Charlotte
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
招募中2/3 期
- Levine Cancer Institute, Charlotte
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
招募中1/2 期
- Atrium Health Levine Cancer Institute, Charlotte
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
招募中3 期
- Levine Cancer Institute, Charlotte
- Oncology Specialists of Charlotte, Charlotte
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
招募中1/2 期
- Carolina Biooncology Institute, Huntersville · 距离 13 英里
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
招募中1/2 期
- Carolina Biooncology Institute, Huntersville · 距离 13 英里
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
招募中1/2 期
- Levine Cancer Institute, Charlotte
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
招募中1 期
- Carolina BioOncology Institute, Huntersville · 距离 13 英里
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
招募中1/2 期
- Carolina BioOncology Institute, Huntersville · 距离 13 英里
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
招募中1/2 期
- Levine Cancer Institute (LCI)- Atrium Health, Charlotte
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
招募中1/2 期
- Carolina BioOncology Institute, Huntersville · 距离 13 英里
其他城市的 转移性癌症试验
- Houston, TX104 项研究
- New York City, NY93 项研究
- Nashville, TN70 项研究
- Boston, MA63 项研究
- Los Angeles, CA57 项研究
- St. Louis, MO54 项研究
- Arlington, VA53 项研究
- Philadelphia, PA46 项研究
- Chicago, IL45 项研究
- San Antonio, TX44 项研究
- Washington, DC43 项研究
- Dallas, TX42 项研究
Charlotte的其他研究
- 癌症（所有类型）27 项研究
- 乳腺癌22 项研究
- 多发性骨髓瘤21 项研究
- 非小细胞肺癌19 项研究
- 急性髓系白血病16 项研究
- 肥胖症16 项研究
- 超重15 项研究
- 结直肠癌13 项研究
- 卵巢癌12 项研究
- 心力衰竭11 项研究
- 头颈鳞状细胞癌10 项研究
- 慢性阻塞性肺病9 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。